Crossing survival curves in low- and intermediate-risk patients: the nemesis of TAVI
Study performing a pooled analysis of comparative clinical trials of TAVI versus surgical aortic valve replacement in low- to intermediate-risk patient populations with a minimum follow-up of 5 years.